Friends Or Foes? The Changing Regulator/Industry Relationship In Europe
Executive Summary
Top leaders discuss the evolving concept of transparency, more proactive risk management, and industry/regulator interactions at a conference marking 50 years of the EU pharmaceutical legislation.
You may also be interested in...
New EFPIA Head Sought As Bergström Decides To Seek Fresh Pastures
The Swedish head of the European Federation of Pharmaceutical Industries and Associations is moving on after five years as EFPIA director general, but will stay at the helm to help find his successor.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.